Omnicell Inc (OMCL)
44.96
+0.85
(+1.93%)
USD |
NASDAQ |
Nov 22, 14:49
Omnicell Shareholders Equity (Quarterly): 1.231B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.231B |
June 30, 2024 | 1.203B |
March 31, 2024 | 1.189B |
December 31, 2023 | 1.189B |
September 30, 2023 | 1.187B |
June 30, 2023 | 1.164B |
March 31, 2023 | 1.143B |
December 31, 2022 | 1.130B |
September 30, 2022 | 1.135B |
June 30, 2022 | 1.093B |
March 31, 2022 | 1.075B |
December 31, 2021 | 1.147B |
September 30, 2021 | 1.111B |
June 30, 2021 | 1.053B |
March 31, 2021 | 1.011B |
December 31, 2020 | 967.50M |
September 30, 2020 | 918.40M |
June 30, 2020 | 887.46M |
March 31, 2020 | 878.50M |
December 31, 2019 | 845.25M |
September 30, 2019 | 807.53M |
June 30, 2019 | 773.24M |
March 31, 2019 | 730.48M |
December 31, 2018 | 679.62M |
September 30, 2018 | 619.24M |
Date | Value |
---|---|
June 30, 2018 | 588.64M |
March 31, 2018 | 574.50M |
December 31, 2017 | 554.34M |
September 30, 2017 | 472.50M |
June 30, 2017 | 449.50M |
March 31, 2017 | 438.94M |
December 31, 2016 | 431.61M |
September 30, 2016 | 427.56M |
June 30, 2016 | 413.20M |
March 31, 2016 | 410.50M |
December 31, 2015 | 402.39M |
September 30, 2015 | 391.54M |
June 30, 2015 | 399.35M |
March 31, 2015 | 405.45M |
December 31, 2014 | 390.10M |
September 30, 2014 | 378.90M |
June 30, 2014 | 377.62M |
March 31, 2014 | 365.18M |
December 31, 2013 | 349.00M |
September 30, 2013 | 357.79M |
June 30, 2013 | 333.73M |
March 31, 2013 | 321.79M |
December 31, 2012 | 307.55M |
September 30, 2012 | 296.51M |
June 30, 2012 | 287.52M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
845.25M
Minimum
Dec 2019
1.231B
Maximum
Sep 2024
1.078B
Average
1.121B
Median
Shareholders Equity (Quarterly) Benchmarks
10x Genomics Inc | 722.80M |
American Shared Hospital Services | 26.42M |
Astrana Health Inc | 704.62M |
Cryo-Cell International Inc | -9.559M |
P3 Health Partners Inc | 120.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.304B |
Total Liabilities (Quarterly) | 1.072B |
Debt to Equity Ratio | 0.4645 |
Current Ratio | 1.052 |
Net Debt Paydown Yield | -0.04% |